BIND THERAPEUTICS INC / PFIZER INC. / Acquisition / Private / £29m

Synopsis

Sale of BIND Therapeutics, a clinical-stage developer of Accurins, highly selective targeted and programmable biopharmaceutical therapeutics, to Pfizer, via a stalking horse bankruptcy auction.

Principals

target

Bind Therapeutics

bidder

Pfizer

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

latham & watkins

HQ - New York, United States

legal advisors

target

5445

Deals

£ 3,505.44 B

Total Value